These analyses identified variants in angiotensin II receptor type 1 (AGTR1), APOE, carboxypeptidase B2 (CPB2), and coagulation factor XII (F12) as conferring risk of CHD. This evidence concerns the gene CPB2 and coronary artery disorder.